These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 28153104

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A.
    Lancet; 2016 Jan 30; 387(10017):435-43. PubMed ID: 26559744
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.
    Bangalore S, Toklu B, Gianos E, Schwartzbard A, Weintraub H, Ogedegbe G, Messerli FH.
    Am J Med; 2017 Jun 30; 130(6):707-719.e8. PubMed ID: 28109971
    [Abstract] [Full Text] [Related]

  • 6. Intensive versus standard blood pressure control in older persons with or without diabetes: a systematic review and meta-analysis of randomised controlled trials.
    Seidu S, Willis H, Kunutsor SK, Khunti K.
    J R Soc Med; 2023 Apr 30; 116(4):133-143. PubMed ID: 36825537
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.
    Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.
    Thomopoulos C, Parati G, Zanchetti A.
    J Hypertens; 2014 Dec 11; 32(12):2285-95. PubMed ID: 25255397
    [Abstract] [Full Text] [Related]

  • 14. Optimal blood pressure targets for patients with hypertension: a systematic review and meta-analysis.
    Sakima A, Satonaka H, Nishida N, Yatsu K, Arima H.
    Hypertens Res; 2019 Apr 11; 42(4):483-495. PubMed ID: 30948822
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
    Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A.
    JAMA; 2015 Feb 10; 313(6):603-15. PubMed ID: 25668264
    [Abstract] [Full Text] [Related]

  • 17. Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials.
    Bangalore S, Kumar S, Volodarskiy A, Messerli FH.
    Heart; 2013 May 10; 99(9):601-13. PubMed ID: 22914531
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular outcomes in patients with diabetes when initiating blood pressure lowering at baseline SBP between 130 and 140 mm Hg: A meta-analysis.
    Wang S, Djama NM, Lai Y, Li H, Liao W, Liao Y, Bin J.
    J Clin Hypertens (Greenwich); 2019 Feb 10; 21(2):220-229. PubMed ID: 30637947
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.